(Q44176259)

30 November 2017

Airway inflammation in premenstrual asthma (English)

1 reference

30 November 2017

0 references

0 references

I Kivilcim Oguzulgen

1

1 reference

30 November 2017

Haluk Turktas

series ordinal

2

1 reference

30 November 2017

Deniz Erbas

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

39

1 reference

30 November 2017

6

1 reference

30 November 2017

517-522

1 reference

Premenstrual asthma: still poorly understood

30 November 2017

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Effects of exogenous female sex-steroid hormones on lymphocyte beta 2-adrenoceptors in normal females

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Use of induced sputum cell counts to investigate airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Absence of changes in airway responsiveness during the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

The effect of sodium meclofenamate in premenstrual asthma: a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Premenstrual exacerbation of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Gonadotrophin-releasing hormone analogues: a novel treatment for premenstrual asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Morbidity in asthma in relation to the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-120004921

21 January 2018

Identifiers

DOI

10.1081/JAS-120004921

1 reference

30 November 2017

1 reference